Ontogeny and regulation of matrix metalloproteinase activity in the zebrafish embryo by in vitro and in vivo zymography

被引:34
作者
Crawford, BD [1 ]
Pilgrim, DB [1 ]
机构
[1] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada
基金
加拿大健康研究院;
关键词
matrix metalloproteinases; GM6001; tissue inhibitors of metalloproteinases; extracellular matrix; collagen; zebrafish; in vivo zymography;
D O I
10.1016/j.ydbio.2005.06.035
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Remodeling of the extracellular matrix (ECM) during development, angiogenesis, wound healing, tumor metastasis, and other morphogenetic processes depends on the exquisitely regulated activities of matrix metalloproteinases (MMPs). Yet very little is known about the activity patterns of these proteases in vivo. We have employed fluorescent MMP-substrates, both in vitro and in vivo, to characterize patterns of MMP activity in the zebrafish embryo. Qualitatively similar patterns of degradation are detected using native Type 1 or Type IV collagen substrates, suggesting that multiple MMPs are being regulated concomitantly. MMP activity is observed primarily in ECM-rich structures predicted to be undergoing active remodeling, such as the perichordal sheath and somite boundaries. Patterns of Type I and Type IV collagen hydrolysis are similar, but not identical in embryos of any given stage. Conventional gelatin zymography shows MMPs present in embryos as early as 3-somites (11 h) and our in vivo assays detect Type IV collagen degradation at somite boundaries as early as 4-somites (11.5 h). However, we are unable to detect significant in vitro activity using homogenates made from embryos prior to Prim-16 (31 h). Mixed lysate assays demonstrate that this is the result of endogenous inhibitors present in early embryos, suggesting a model of matrix remodeling regulated by spatially heterogeneous MMP inhibition. (C) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:405 / 414
页数:10
相关论文
共 41 条
[1]  
Abramoff MD., 2004, Biophot. Int., V11, P36, DOI DOI 10.1201/9781420005615.AX4
[2]  
[Anonymous], 2001, Celltransmissions
[3]   Structure and biological activity of the extracellular matrix [J].
Aumailley, M ;
Gayraud, B .
JOURNAL OF MOLECULAR MEDICINE-JMM, 1998, 76 (3-4) :253-265
[4]   Metalloproteinase inhibitors: biological actions and therapeutic opportunities [J].
Baker, AH ;
Edwards, DR ;
Murphy, G .
JOURNAL OF CELL SCIENCE, 2002, 115 (19) :3719-3727
[5]   Functional structure and composition of the extracellular matrix [J].
Bosman, FT ;
Stamenkovic, I .
JOURNAL OF PATHOLOGY, 2003, 200 (04) :423-428
[6]   In vivo molecular target assessment of matrix metalloproteinase inhibition [J].
Bremer, C ;
Tung, CH ;
Weissleder, R .
NATURE MEDICINE, 2001, 7 (06) :743-748
[7]   Tissue inhibitors of metalloproteinases: evolution, structure and function [J].
Brew, K ;
Dinakarpandian, D ;
Nagase, H .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 2000, 1477 (1-2) :267-283
[8]   Quest for selectivity in inhibition of matrix metalloproteinases [J].
Brown, S ;
Meroueh, SO ;
Fridman, R ;
Mobashery, S .
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2004, 4 (12) :1227-1238
[9]   FRAGMENTS OF HUMAN FIBROBLAST COLLAGENASE - PURIFICATION AND CHARACTERIZATION [J].
CLARK, IM ;
CAWSTON, TE .
BIOCHEMICAL JOURNAL, 1989, 263 (01) :201-206
[10]  
Crawford BD, 2003, MOL BIOL CELL, V14, P3065, DOI 10.1091/mbc.E02-08-0537